Clasado Biosciences is stepping up its engagement in the Global Prebiotic Association (GPA) by boosting its membership to executive board level, according to a press release.

As part of the increased engagement, senior leadership at Clasado have been appointed to join GPA committees. CEO Per Rehné has joined the association Board; Dr. Frederic Narbel, VP of Sales B2B, has joined the GPA Communications committee as Vice-Chair and R&D Director; and Dr. Lucien Harthoorn has been appointed to the Science & Technical committee.

“Dr. Harthoorn and I are delighted to join the GPA Technical & Science and Communications committees respectively,” commented Dr. Narbel. “Our team believes in leading from the front and being a real catalyst for change. As the prebiotic category continues its remarkable upward trajectory, we are proud to share our expertise and perspective and support the long-term success of industry.”

As part of the Board, Clasado will play a more instrumental role within GPA, which hosts events and workshops and develops resources to promote the benefits and science of prebiotics, with the mission of raising awareness of prebiotics around the world amongst consumers, brands, and healthcare professionals.

Related: Prebiotic Market At a “Tipping Point,” According to Clasado Global Prebiotic Association to Award Young Researchers ITC Publishes 2021 Prebiotic Report

Rehné commented in the press release: “By amplifying our membership of the GPA, we intend to not just further accelerate our efforts in conveying the important messages surrounding gut health, but to contribute to a deeper scientific understanding of the gut microbiome. In terms of our understanding of the significant role gut bacteria plays in our physical wellbeing, we are only scratching the surface of its potential—it's an exciting time for the prebiotic category. By partnering with GPA at board level and stepping up our committee involvement, we will accelerate prebiotic awareness and help to make better gut health more accessible around the globe.”

Clasado is the developer and manufacturer of Bimuno, a prebiotic ingredient supported by more than 20 clinical trials and over 100 scientific publications.